Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.395 USD | -0.36% | -0.36% | +4.10% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.10% | 348M | |
+32.90% | 664B | |
+29.29% | 567B | |
-7.16% | 354B | |
+19.27% | 330B | |
+4.45% | 286B | |
+13.38% | 234B | |
+5.15% | 199B | |
-9.78% | 196B | |
-5.14% | 148B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- Precigen To Sell Trans Ova Genetics Unit For $170 Million; Shares Climb